Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Dicerna Pharmaceuticals Inc | 25,000 | reported | 18 Jul 2017 | tx 4+80,000 |
| NeurogesX Inc | 23,333 | reported | 28 May 2009 | tx 3+23,333 |
| OCULAR THERAPEUTIX, INC | 18,000 | reported | 18 Jun 2021 | tx 13+141,044−50,000 |
| PHARMACOPEIA DRUG DISCOVERY INC | 15,000 | reported | 30 Apr 2008 | tx 4+40,572 |
| DISCOVERY LABORATORIES INC /DE/ | 15,000 | reported | 03 Feb 2021 | tx 21+307,294−17 |
| ADOLOR CORP | 11,000 | reported | 26 May 2004 | tx 3+251,000 |
| LIGAND PHARMACEUTICALS INC | 10,000 | reported | 23 Dec 2008 | tx 1+10,000 |
| Ocean Power Technologies, Inc. | 9,908 | reported | 04 Oct 2012 | tx 2+20,171 |
| APPLIED GENETIC TECHNOLOGIES CORP | 6,200 | reported | 19 Nov 2015 | tx 2+15,575 |
| Ophthotech Corp. | 900 | reported | 02 Sept 2014 | tx 32+151,077−102,100 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 Jun 2021 | GRANT_AWARD | OCULAR THERAPEUTIX, INC | 18,000 | 0.00 USD | deriv |
| 03 Feb 2021 | GRANT_AWARD | DISCOVERY LABORATORIES INC /DE/ | 15,000 | 0.00 USD | deriv |
| 03 Dec 2020 | SALE | OCULAR THERAPEUTIX, INC | 25,000 | — | |
| 03 Dec 2020 | EXERCISE | OCULAR THERAPEUTIX, INC | 18,000 | 3.90 USD | |
| 03 Dec 2020 | EXERCISE | OCULAR THERAPEUTIX, INC | 7,000 | 8.14 USD | |
| 03 Dec 2020 | EXERCISE | OCULAR THERAPEUTIX, INC | 18,000 | 0.00 USD | deriv |
| 03 Dec 2020 | EXERCISE | OCULAR THERAPEUTIX, INC | 7,000 | 0.00 USD | deriv |
| 25 Jun 2020 | GRANT_AWARD | OCULAR THERAPEUTIX, INC | 18,000 | 0.00 USD | deriv |
| 22 May 2020 | PURCHASE | DISCOVERY LABORATORIES INC /DE/ | 3,500 | 7.25 USD | |
| 22 May 2020 | PURCHASE | DISCOVERY LABORATORIES INC /DE/ | 3,500 | 0.00 USD | derivfirst after silence |
| 28 Jun 2019 | GRANT_AWARD | DISCOVERY LABORATORIES INC /DE/ | 40,000 | 0.00 USD | deriv |
| 11 Jun 2019 | GRANT_AWARD | OCULAR THERAPEUTIX, INC | 18,000 | 0.00 USD | deriv |
| 24 Dec 2018 | GRANT_AWARD | DISCOVERY LABORATORIES INC /DE/ | 15,000 | 0.00 USD | |
| 24 Dec 2018 | GRANT_AWARD | DISCOVERY LABORATORIES INC /DE/ | 32,000 | 0.00 USD | deriv |
| 21 Nov 2018 | CONVERSION | DISCOVERY LABORATORIES INC /DE/ | 850 | — | |
| 21 Nov 2018 | CONVERSION | DISCOVERY LABORATORIES INC /DE/ | 17 | — | deriv |
| 14 Jun 2018 | GRANT_AWARD | OCULAR THERAPEUTIX, INC | 18,000 | 0.00 USD | deriv |
| 18 Jul 2017 | GRANT_AWARD | Dicerna Pharmaceuticals Inc | 25,000 | 0.00 USD | deriv |
| 01 Jun 2017 | GRANT_AWARD | OCULAR THERAPEUTIX, INC | 13,500 | 0.00 USD | deriv |
| 13 Feb 2017 | PURCHASE | DISCOVERY LABORATORIES INC /DE/ | 17 | — | deriv |
| 13 Feb 2017 | PURCHASE | DISCOVERY LABORATORIES INC /DE/ | 17,000 | — | derivfirst after silence |
| 04 Aug 2016 | GRANT_AWARD | DISCOVERY LABORATORIES INC /DE/ | 4,348 | 0.00 USD | |
| 04 Aug 2016 | GRANT_AWARD | DISCOVERY LABORATORIES INC /DE/ | 15,000 | 0.00 USD | deriv |
| 14 Jun 2016 | GRANT_AWARD | Dicerna Pharmaceuticals Inc | 15,000 | 0.00 USD | deriv |
| 02 Jun 2016 | GRANT_AWARD | OCULAR THERAPEUTIX, INC | 13,500 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 22 May 2020.